Rick Costantino is CTO and co-founder of Group14 Technologies, a global manufacturer of advanced silicon-carbon anode battery materials, which deliver up to 50% increased energy density across thousands of cycles for any application currently powered by a lithium-ion battery. Based in Woodinville, Washington, Group14 is manufacturing and delivering its mass-market product at commercial scale to customers in sectors including EVs, consumer electronics, aviation and more. Rick has over 30 years of experience developing stable, high-performance products at the molecular level, spanning chemical and biopharmaceutical industries for companies such as Genentech, Alkermes, and Nastech. Rick’s efforts have culminated in numerous commercial products, from marketed therapeutics to electrode materials for advanced ultracapacitors and lead acid batteries. Rick holds more than 50 U.S. patents and has over 50 publications. Prior to founding Group14, he served as the VP of Research and Development at EnerG2. Previously, Rick served as the CSO of delivery at MDRNA Inc. and CSO at G2B Pharma. Rick holds a B.S. and M.S. in Chemical Engineering from Johns Hopkins University and a Ph.D. in Chemical Engineering from M.I.T.